The Expression and Correlation of miR-195, miR-125 and Calreticulin in Diffuse Large B-Cell Lymphoma.
10.19746/j.cnki.issn.1009-2137.2023.01.019
- Author:
Yan LI
1
;
Xiao-Yan LIU
2
;
Gui-Rong CUI
2
;
Xiao-Yang KONG
2
;
Lin YANG
3
;
Jian-Min LUO
3
Author Information
1. Department of Hematology, Handan First Hospital, Handan 056002, Hebei Province, China.E-mail: liyan19680404@163.com.
2. Department of Hematology, Handan First Hospital, Handan 056002, Hebei Province, China.
3. Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang 050004, Hebei Province, China.
- Publication Type:Journal Article
- Keywords:
calreticulin;
diffuse large B-cell lymphoma;
microRNA-125;
microRNA-195
- MeSH:
Humans;
MicroRNAs/genetics*;
Ki-67 Antigen/metabolism*;
Calreticulin/metabolism*;
Prognosis;
Lymphoma, Large B-Cell, Diffuse/genetics*;
Lactate Dehydrogenases/metabolism*
- From:
Journal of Experimental Hematology
2023;31(1):120-124
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the expression and correlation of microRNA-195 (miR-195), miR-125 and calreticulin in diffuse large B-cell lymphoma (DLBCL).
METHODS:From April 2020 to April 2021, 80 DLBCL patients with complete data archived by the Pathology Department of Handan First Hospital and The Second Hospital of Hebei Medical University were selected as the study group, and 70 patients with reactive lymph node hyperplasia were selected as the control group. The expressions of miR-195 and miR-125 were detected by real-time fluorescence quantitative PCR, and the expression of calreticulin was detected by Western blot. Pearson correlation was used to analyze the correlation between miR-195, miR-125, calreticulin and DLBCL, and ROC curve was used to analyze the predictive value of miR-195, miR-125 and calreticulin for DLBCL.
RESULTS:Compared with the control group, the expression of miR-195 decreased but miR-125 and calreticulin increased in the study group (P<0.001). The expression levels of miR-195, miR-125 and calreticulin were not related to sex, age, primary site and B symptoms of patients with DLBCL, but related to immunophenotype, Ann Arbor stage, lactate dehydrogenase, IPI score, nodule involvement and Ki-67 index. The expression of miR-195 decreased and the expression of miR-125 and calreticulin increased in DLBCL paitents with non-germinal center source, Ann Arbor stage III-IV, lactate dehydrogenase > 245 U/L, IPI score 3-5, nodule involvement≥2 and Ki-67 index≥75% (P<0.05). Pearson correlation analysis showed that miR-195 and miR-125 were negatively correlated (r=-0.536, P=0.001), miR-195 and calreticulin were negatively correlated (r=-0.545, P=0.001), while miR-125 and calreticulin were positively correlated (r=0.523, P=0.001). ROC curve showed that compared with the single diagnosis of miR-195, miR-125 and calreticulin, the combination of the three items had higher predictive value for DLBCL (P<0.001).
CONCLUSION:The expression of miR-195 decreases and the expression of miR-125 and calreticulin increase in patients with DLBCL. Along with the increase of disease stage and IPI score, the decrease of miR-195 and the increase of miR-125 and calreticulin aggravate gradually. The three items may participate in the occurrence and progress of DLBCL.
